ResearcherAlexandria UniversityNo recent work listed
Samar M. Etman
Matched on ORCID iD 0000-0002-4703-9864; OpenAlex author ID A5087426212.
Their work
Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.
- Pancreatic cancer papers
- 3 (first author 3, last author 0)
- Pancreatic cancer trials
- 0
- Pancreatic cancer grants
- 0
- Collaborators
- 2
2020: 2 papers · 2021: 1 paper
Papers 3
- Undaria pinnatifida fucoidan nanoparticles loaded with quinacrine attenuate growth and metastasis of pancreatic cancer. First author DOI 10.1016/j.ijbiomac.2020.12.109↗
- Novel fucoidan based bioactive targeted nanoparticles from Undaria Pinnatifida for treatment of pancreatic cancer. First author DOI 10.1016/j.ijbiomac.2019.12.177↗
- Lactoferrin/Hyaluronic acid double-coated lignosulfonate nanoparticles of quinacrine as a controlled release biodegradable nanomedicine targeting pancreatic ca… First author DOI 10.1016/j.ijpharm.2020.119097↗
Closest collaborators
The 2 strongest of 2 ranked by shared papers, trials and grants, with recent and small-team work weighing most.
- Yosra S.R. Elnaggar · 3 shared papers, 2020–2021
- Paper Novel fucoidan based bioactive targeted nanoparticles from Undaria Pinnatifida for treatment of pancreatic cancer. DOI 10.1016/j.ijbiomac.2019.12.177↗
- Paper Undaria pinnatifida fucoidan nanoparticles loaded with quinacrine attenuate growth and metastasis of pancreatic cancer. DOI 10.1016/j.ijbiomac.2020.12.109↗
- Paper Lactoferrin/Hyaluronic acid double-coated lignosulfonate nanoparticles of quinacrine as a controlled release biodegrada… DOI 10.1016/j.ijpharm.2020.119097↗
- Ossama Y. Abdallah · 3 shared papers, 2020–2021
- Paper Novel fucoidan based bioactive targeted nanoparticles from Undaria Pinnatifida for treatment of pancreatic cancer. DOI 10.1016/j.ijbiomac.2019.12.177↗
- Paper Undaria pinnatifida fucoidan nanoparticles loaded with quinacrine attenuate growth and metastasis of pancreatic cancer. DOI 10.1016/j.ijbiomac.2020.12.109↗
- Paper Lactoferrin/Hyaluronic acid double-coated lignosulfonate nanoparticles of quinacrine as a controlled release biodegrada… DOI 10.1016/j.ijpharm.2020.119097↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.